close up photo of two women tying their shoelaces before jogging

Image source: Adobe Stock/Svitlana

News • New study

Can physical exercise enhance the effect of chemotherapy against breast cancer?

Approximately 9,000 women are diagnosed with breast cancer each year in Sweden, a number that has been steadily increasing since the 1990s. However, the prognosis for breast cancer has improved, more and more women can now be cured with a combination of surgery, radiotherapy and medical treatment.

portrait of Jana de Boniface
Jana de Boniface

Image source: Karolinska Institutet; photo: Peter Knutson

Neoadjuvant chemotherapy (NACT) is increasingly used in breast cancer. The best proof of NACT efficacy is pathological complete response (pCR), i.e. the absence of invasive tumour on post-NACT on surgical histopathology. "While it is known that physical exercise can help patients to better tolerate often harsh cancer treatments, it is an emerging area of research to understand if and how exercise exerts anti-tumour effects and improves oncological outcomes", says Jana de Boniface, principal investigator of the trial and associate professor in the Breast Surgery Group, Department of Molecular Medicine and Surgery. 

The Neo-ACT trial opened for recruitment in September 2022, and it is estimated that inclusion may be completed in December 2025. A trial protocol has been published in the journal PLOS One.

Source: Karolinska Institutet


Read all latest stories

Related articles


News • Relapse rate research

Breast cancer: Fertility preservation measures do not increase recurrence risk

A new study shows that women with a breast cancer diagnosis undergoing procedures for fertility preservation are not at increased risk of recurrence of the disease or disease-specific mortality.


News • Making tumours susceptible to chemo

Breast cancer: target protein may hold key to therapy success

A rare variant of a protein present in nearly all human cells may hold the key to improving the effectiveness of breast cancer treatment, according to University of Manchester research.  


News • Prevalence of metastatic BRCA

New research shows scale of secondary breast cancer in England

A cancer researcher and consultant has estimated for the first time how many women are living with secondary breast cancer in England – in new research which could help to shape cancer services.

Related products

3DQuorum SmartSlices

Artificial Intelligence

Hologic · 3DQuorum SmartSlices

Hologic, Inc.
50° wide-angle Tomosynthesis


Siemens Healthineers · 50° wide-angle Tomosynthesis

Siemens Healthcare GmbH
Advanced Breast-CT - nu:view

Mammo CT

AB-CT · Advanced Breast-CT - nu:view

AB-CT – Advanced Breast-CT GmbH

Digital Mammography

Drtech Europe · Aidia

Subscribe to Newsletter